ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos

News   Mar 18, 2016

 
ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos
 
 
 

RELATED ARTICLES

Automated Robotic Device Enables Faster Blood Testing

News

Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.

READ MORE

63 New Genetic Variations in DNA Increase Prostate Cancer Risk

News

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.

READ MORE

UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics

News

Partnership will include broad range of value-based programs, rewarding high-quality, easily accessible laboratory services at the best value and real-time data sharing to drive more personalized care support.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy